Status:
COMPLETED
Comparison of Two Electroencephalograms (EEG) Monitors in Patients Undergoing General Intravenous Anesthesia
Lead Sponsor:
Hopital Foch
Conditions:
General Anesthesia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Quantium Medical Company has an ElectroEncephalograph-based (EEG-based) algorithm with two outputs: qCON for unconsciousness and qNOX for anti-nociception. qCON, is designed to provide information abo...
Eligibility Criteria
Inclusion
- Patients above 18 years,
- Patients affiliated to a national insurance scheme or benefiting from such a program,
- Patients having given their written consent,
- Patients that must benefit from a general anesthesia by intravenous drugs (propofol and remifentanil),
- For the patients taken care in ambulatory surgery, having a telephone and agreeing to communicate their phone number.
Exclusion
- Pregnant or breast-feeding Women,
- Patients having a limit of use of the Bispectral Index (BIS) or qCON monitors,
- Patients having a contraindication to Propofol and/or to Remifentanil.
Key Trial Info
Start Date :
December 4 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 21 2018
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT03753217
Start Date
December 4 2018
End Date
December 21 2018
Last Update
February 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Foch
Suresnes, France, 92150